Duoguping stock trading knowledge column, providing novice investors with zero-based stock trading tutorials, technical analysis skills, position management methods, and stock market risk education to promote rational investing.
Many newcomers to the US stock market are instantly drawn to the words "high dividend"—collecting payouts year after year sounds like a can't-lose proposition. Among the many high-dividend sectors,...
For investors who have long followed the dividend pharma sector, a striking phenomenon is emerging in the 2026 U.S. stock market: large drugmakers, long known for steady dividends and defensive tra...
US Pharmaceutical Giants Q3 Earnings Analysis: High Dividends and AI Technology Dual-Driven Reshaping of Investment Landscape\nIn the third quarter of 2026, the US pharmaceutical industry ...
High-Dividend Pharmaceutical Giants' AI Computing Investment Boom: 2026 Pharmaceutical-Technology Dual Engine Reshaping Industry LandscapeAt this critical moment of transformation and brea...
AI Pharma Revolution: How High Dividend and AI Technology Reshape the Industry Landscape for US Pharma Giants' Dual-Drive Strategy In 2026, AI technology is penetrating every aspect of the...
In August 2026, as the Fed’s rate hike cycle neared its end, demand for defensive investments continued to rise. Among various investment sectors, high-dividend pharma, with its high dividends, sta...
At the end of the interest rate hiking cycle, the defensive value of dividend pharmaceutical stocks becomes prominent, while the proliferation of AI computing chips is driving pharmaceutical compan...
Merck & Co. Q3 Earnings Beat Expectations, Dividend Increased by 10%, Boosting Investment in AI Drug R&D: Merck Pharma Adds Another High Dividend Growth Stock On August 16, 2026, the globa...
In 2026, the US stock market is undergoing a profound transformation driven by AI technology, particularly in the pharmaceutical industry. As traditional defensive investment targets, high-dividend...
In the context of the new drug discovery efficiency bottleneck in the global pharmaceutical industry in 2026, breakthroughs in AI computing chips bring new growth momentum to high-dividend pharmaceuti...
Explore more stock market analysis content
